Metabolix mit Potenzial

10,75 Mio. $ Offering

http://ir.yield10bio.com/news-releases/...pricing-1075-million-equity

RS 1/40

• Kurs vor dem RS 0,18$
  
• Faktor 40
  
• 0,18$*40 = 7,20$
  
• wie so oft, fallen Aktien nach einem RS
  
• die Nasdaq 1$ Regel wird jetzt wieder eingehalten
  

https://seekingalpha.com/news/...d10-bio-to-reverse-split-shares-1-40

Zahlen für Q1/20

• Umsatz 0,2 Mio. $
  
• Verlust 3,6 Mio. $
  
• Cash 10 Mio. $
  

"The Company anticipates total net cash usage during 2020 in a range of approximately $9.0 million to $9.5 million."

"The Company's present capital resources are expected to fund its planned operations into the second quarter of 2021. Yield10's ability to continue operations after its current cash resources are exhausted depends on its ability to obtain additional financing, including public or private equity financing, secured or unsecured debt financing, and receipt of additional government research grants, as well as licensing or other collaborative arrangements."

http://ir.yield10bio.com/news-releases/...irst-quarter-2020-financial

5,2 Mio. $ Offering

• 835k neue Aktien zu je 4,25$
  

http://ir.yield10bio.com/news-releases/...-52-million-public-offering

12,7 Mio. $ Offering

• 1,04 Mio. neue Aktien zu je 12,25$
  

https://seekingalpha.com/news/...eld10-bio-secures-127m-capital-raise